Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
JAMA. 2006 Nov 8;296(18):2203; author reply 2203-4. doi: 10.1001/jama.296.18.2203-a.
JAMA. 2006.
PMID: 17090763
No abstract available.